Changes in liver fatty acid-binding protein in rat enzyme-altered foci

Cancer Letters

Volumn 128, Issue 1, 1998, Pages 1-10

  Thullberg, M ^a   Grasl Kraupp, B ^b   Hogberg J ^a   Garberg, P ^c  

^a NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c PFIZER INC   (United States)

Author keywords

Diethylnitrosamine; Liver fatty acid binding protein; Rat enzyme altered foci

Indexed keywords

DIETHYLNITROSAMINE; FATTY ACID BINDING PROTEIN; GLUTATHIONE TRANSFERASE; LIVER ENZYME; NAFENOPIN; PHENOBARBITAL; POLYCHLORINATED BIPHENYL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LIVER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODY SPECIFICITY; CARCINOGENS; CARRIER PROTEINS; DIETHYLNITROSAMINE; FATTY ACID-BINDING PROTEINS; FEMALE; HEPATECTOMY; IMMUNE SERA; LIVER; MYELIN P2 PROTEIN; NAFENOPIN; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PHENOBARBITAL; POLYCHLORINATED BIPHENYLS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0032486334     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00040-8     Document Type: Article

References (25)

1. Birt D.F., Kris E.S., Choe M., Pelling J.C. Dietary energy and fat effects on tumor promotion. Cancer Res. 52:1992;2035-2039.
2. Roebuck B.D. Dietary fat and the development of pancreatic cancer. Lipids. 27:1992;804-846.
3. Rogers A.E., Longnecker M.P. Dietary and nutritional influences on cancer: a review of epidemiologic and experimental data. Lab. Invest. 59:1988;729-759.
4. N.M. Bass, R.M. Kaikaus, K. Ockner, Physiology and molecular biology of hepatic cytosolic fatty acid-binding protein, in: N. Tavoloni, P.D. Berk (Eds.), Hepatic Transport and Bile Secretion: Physiology and Pathophysiology, Raven Press, New York, 1993, pp. 421-446.
5. Veerkamp J.H., van Kuppevelt T.H.M.S.M., Maatman R.G.H.J., Prinsen C.F.M. Structural and functional aspects of cytosolic fatty acid-binding proteins. Prostaglandins Leukotrienes Essent. Fatty Acids. 49:1993;887-906.
6. Sorof S. Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev. 13:1994;317-336.
7. Glatz J.F.C., Vork M.M., Cistola D.P., van der Vusse G.J. Cytoplasmic fatty acid binding protein: significance for intracellular transport of fatty acids and putative role on signal transduction pathways. Prostaglandins Leukotrienes Essent. Fatty Acids. 48:1993;33-41.
8. Keler T., Barker C.S., Sorof S. Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen. Proc. Natl. Acad. Sci. USA. 89:1992;4830-4834.
9. Custer R.P., Sorof S. Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes. Proc. Natl. Acad. Sci. USA. 81:1984;6738-6742.
10. Bassuk J.A., Tsichlis P.N., Sorof S. Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes. Proc. Natl. Acad. Sci. USA. 84:1987;7547-7551.
11. Khan S.H., Sorof S. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc. Natl. Acad. Sci. USA. 91:1994;848-852.
12. Khan A.H., Sorof S. Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc. Natl. Acad. Sci. USA. 87:1990;9401-9405.
13. Sorof S., Custer R.P. Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Cancer Res. 47:1987;210-220.
14. Roomi M.W., Vincent S.H., Farber E., Muller-Eberhard U. Decreased cytosolic levels of the heme binding Z protein in rat hepatocyte nodules and hepatocellular carcinomas. Cancer Lett. 43:1988;55-58.
15. Peraino C., Staffeldt E.F., Carnes B.A., Ludemann V.A., Blomquist J.A., Vesselinovitch S.D. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 44:1984;3340-3347.
16. Kraupp-Grasl B., Huber W., Putz B., Gerbracht U., Schulte-Hermann R. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Cancer Res. 50:1990;3701-3708.
17. Kraupp-Grasl B., Huber W., Taper H., Schulte-Hermann R. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 51:1991;666-671.
18. Bansal M.P., Oborn C.J., Danielson K.G., Medina D. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis. 10:1989;541-546.
19. Paulussen R.J.A., Geelen M.J.H., Beyen A.C., Veerkamp J.H. Immunochemical quantitation of fatty-acid-binding proteins. I. Tissue and intracellular distribution, postnatal development and influence of physiological conditions on rat heart and liver FABP. Biochim. Biophys. Acta. 1001:1989;201-209.
20. Dörmann P., Börchers T., Korf U., Højrup P., Roepstorff P., Spener F. Amino acid exchange and covalent modification by cysteine and glutathione explain isoforms of fatty acid-binding protein occurring in bovine liver. J. Biol. Chem. 268:1993;16286-16292.
21. Odani S., Okazaki Y., Kato C., Uchiumi T., Takahashi Y. On the molecular origin of charge heterogeneity of rat liver fatty acid-binding protein (Z-protein). Arch. Biochem. Biophys. 309:1994;81-84.
22. Wilton D.C. Studies on fatty-acid-binding proteins. The purification of rat liver fatty-acid-binding protein and the role of cysteine-69 in fatty acid binding. Biochem. J. 261:1989;273-276.
23. Hosokawa S., Tatematsu M., Aoki T., Nakanowatari J., Igarashi T., Ito N. Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator. Carcinogenesis. 10:1989;2237-2241.
24. Stenius U., Högberg J. GST-P-positive hepatocytes isolated from rats bearing enzyme-altered foci show no signs of p53 protein induction and replicate even when their DNA contains strand breaks. Carcinogenesis. 16:1995;1683-1685.
25. Martens U., Lennartsson P., Högberg J., Stenius U. Low expression of WAF1/CIP1 gene product, p21, in enzyme-altered foci induced in rat liver by diethylnitrosamine or phenobarbital. Cancer Lett. 104:1996;21-26.